UCONN WEBINAR SERIES: SEQUENTIAL DELIVERY OF FIBROBLAST GROWTH FACTOR 2 (FGF2) AND ABALOPARATIDE FROM A LOADED FIBRIN SCAFFOLD EMBEDDED WITH LOADED POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA) MICROPARTICLES
Beyond the science, the webinars will address the social and psychological dimensions of research training. What is the ideal environment to train young scientists? What are the social and cultural barriers? How does the young scholar mesh into the fabric of the organization? In all, attendees to the webinars will appreciate contemporary science in regeneration and the dynamics of transferring that science to the next generation in the workforce enterprise.
The Connecticut Convergence Institute, in partnership with the Advanced Regenerative Manufacturing Institute (ARMI), is producing this webinar series. The webinars will inform participants and the audience on the perspective of young scientists in training conducting research in regenerative engineering supplemented by the interaction with their research mentors. Borne from the institutional experience at the Connecticut Convergence Institute’s signature T32 Doctoral and Young Innovative Investigator Programs as well as UConn’s graduate training, four Webinars will be held.
Sequential delivery of Abaloparatide and Fibroblast Growth Factor 2 from loaded microparticles can be achieved by embedding in a gel scaffold. This approach can be applied to patients requiring bone repair and regeneration as a consequence of osteoporosis..
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
